Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma
β Scribed by Valeria Sebastiani; Paolo Visca; Claudio Botti; Giuseppe Santeusanio; Gregorio Marco Galati; Valentina Piccini; Barbara Capezzone de Joannon; Ugo Di Tondo; Piero Luigi Alo
- Book ID
- 113959039
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 173 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Fatty acid synthase (FAS) is a molecule found in tumor cells from breast carcinomas of patients whose prognosis is very poor. Recently, this molecule has been identified as the key enzyme in fatty acid biosynthesis. This study was done to test the strength of FAS as a prognostic ind
Background. Fatty acid synthase (FASE) is required for fatty acid synthesis. Elevated levels of FASE have been observed in a variety of malignancies. Methods: We examined the expression of FASE in 56 primary squamous cell carcinomas (SCC) of the tongue using immunohistochemistry (IHC) with a monocl
## Abstract Loss of DNA mismatch repair occurs in a variety of malignancies and is associated with genomeβwide instability of microsatellite repeats, a molecular phenotype referred to as microsatellite instability (MSI). MSI is a consistent feature of colorectal and endometrial tumors from patients